Swallowing Difficulties With Medication Intake and Coping Strategies in Patients With Systemic Sclerosis (SWAMECO)

Kurt Hersberger

Status: Completed

Conditions: Adherence to Medication Regime; Scleroderma, Systemic; Coping Behaviour; Systemic Sclerosis; Deglutition Disorders

Study type: Observational

Funder types: Other

Identifiers

NCT02105818

SWAMECO_1

Details and patient eligibility

About

The purpose of this study is the validation of a newly developed self-report questionnaire which aims at determining the prevalence, location and intensity of SWAllowing difficulties with drug intake, and describing the impact on MEdication regimen focusing on COping strategies (SWAMECO).

Full description

The study aims at investigating a cohort of patients with diagnosed systemic sclerosis using the newly developed self-report SWAMECO-questionnaire.

The self-report questionnaire is sub-divided into four sections: detection of swallowing difficulties, coping strategies, risk factors to develop swallowing difficulties and adherence to medication.

This study involves patients with systemic sclerosis. Systemic sclerosis often is accompanied by swallowing disorders which may lead to issues in handling medication regimen with risks for patient safety.

Enrollment: 64 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age >18 years
• diagnosis for systemic sclerosis
• treated in the Reha Rheinfelden
• signed informed consent
• german language skills

Exclusion criteria

Trial design

64 participants in 1 patient group

Systemic sclerosis

Description:

Patients with diagnosed systemic sclerosis treated in the Reha Rheinfelden, Switzerland (European Centre for the Rehabilitation of Scleroderma).